These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19820132)

  • 1. Topical mupirocin/sodium hypochlorite reduces peritonitis and exit-site infection rates in children.
    Chua AN; Goldstein SL; Bell D; Brewer ED
    Clin J Am Soc Nephrol; 2009 Dec; 4(12):1939-43. PubMed ID: 19820132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dialysis: The importance of peritoneal catheter exit-site care.
    Piraino B
    Nat Rev Nephrol; 2010 May; 6(5):259-60. PubMed ID: 20424630
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
    Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.
    Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK
    Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do topical antibiotics reduce exit site infection rates and peritonitis episodes in peritoneal dialysis patients? The Pan Thames Renal Audit.
    Davenport A;
    J Nephrol; 2012; 25(5):819-24. PubMed ID: 22241640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative Effectiveness of Local Application of Chlorhexidine Gluconate, Mupirocin Ointment, and Normal Saline for the Prevention of Peritoneal Dialysis-related Infections (COSMO-PD Trial): a multicenter randomized, double-blind, controlled protocol.
    Nochaiwong S; Ruengorn C; Noppakun K; Panyathong S; Dandecha P; Sood MM; Saenjum C; Awiphan R; Sirilun S; Mongkhon P; Chongruksut W; Thavorn K;
    Trials; 2019 Dec; 20(1):754. PubMed ID: 31856900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial comparing mupirocin and polysporin triple ointments in peritoneal dialysis patients: the MP3 Study.
    McQuillan RF; Chiu E; Nessim S; Lok CE; Roscoe JM; Tam P; Jassal SV
    Clin J Am Soc Nephrol; 2012 Feb; 7(2):297-303. PubMed ID: 22134627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exit-Site Dressing and Infection in Peritoneal Dialysis: A Randomized Controlled Pilot Trial.
    Mushahar L; Mei LW; Yusuf WS; Sivathasan S; Kamaruddin N; Idzham NJ
    Perit Dial Int; 2016; 36(2):135-9. PubMed ID: 26374836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of peritoneal dialysis catheter infections in Saudi peritoneal dialysis patients: the emergence of high-level mupirocin resistance.
    Al-Hwiesh AK; Abdul-Rahman IS; Al-Muhanna FA; Al-Sulaiman MH; Al-Jondebi MS; Divino-Filho JC
    Int J Artif Organs; 2013 Jul; 36(7):473-83. PubMed ID: 23897229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of local mupirocin application on exit-site infection and peritonitis in an Indian peritoneal dialysis population.
    Mahajan S; Tiwari SC; Kalra V; Bhowmik DM; Agarwal SK; Dash SC; Kumar P
    Perit Dial Int; 2005; 25(5):473-7. PubMed ID: 16178481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect on peritoneal dialysis pathogens of changing topical antibiotic prophylaxis.
    Pierce DA; Williamson JC; Mauck VS; Russell GB; Palavecino E; Burkart JM
    Perit Dial Int; 2012; 32(5):525-30. PubMed ID: 22302770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decrease in Staphylococcus aureus exit-site infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site.
    Thodis E; Bhaskaran S; Pasadakis P; Bargman JM; Vas SI; Oreopoulos DG
    Perit Dial Int; 1998; 18(3):261-70. PubMed ID: 9663889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site.
    Wong SS; Chu KH; Cheuk A; Tsang WK; Fung SK; Chan HW; Tong MK
    Perit Dial Int; 2003 Dec; 23 Suppl 2():S153-8. PubMed ID: 17986538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of topical mupirocin on peritoneal dialysis infection in Singapore General Hospital.
    Lim CT; Wong KS; Foo MW
    Nephrol Dial Transplant; 2005 Oct; 20(10):2202-6. PubMed ID: 16046516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients.
    Bernardini J; Bender F; Florio T; Sloand J; Palmmontalbano L; Fried L; Piraino B
    J Am Soc Nephrol; 2005 Feb; 16(2):539-45. PubMed ID: 15625071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of gentamicin and mupirocin in the prevention of exit-site infection and peritonitis in peritoneal dialysis.
    Mahaldar A; Weisz M; Kathuria P
    Adv Perit Dial; 2009; 25():56-9. PubMed ID: 19886318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
    Campbell D; Mudge DW; Craig JC; Johnson DW; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004679. PubMed ID: 28390069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prophylaxis and management of catheter-associated infections in peritoneal dialysis patients: recent studies and guidelines].
    Kopriva-Altfahrt G; Moser E; Prokschi A; Kraus B; Kovarik J
    Wien Klin Wochenschr; 2005; 117 Suppl 6():73-82. PubMed ID: 16437337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.